SNDX – syndax pharmaceuticals, inc. (US:NASDAQ)

News

Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm
Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) for Potential Breaches of Fiduciary Duty By Its Board of Directors
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com